Skip to main content

Propel Bio Management, LLC

SEC CIK
0001969764
Latest filing
Aug 13, 2026

AARD holding history

Aardvark Therapeutics, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AARD overviewAll 13F holders of AARDFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2025
Holdings of AARD by Propel Bio Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−46,408−100.0%Sold outHolders
Q4 202546,408$609.1K0.5%+46,408NewHolders